Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease
Related Experiment Video
Updated: Jun 24, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
1Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, 97006, USA. reddyh@ohsu.edu
Abstract:
Mitochondria are the major source of energy for the normal functioning of brain cells. Increasing evidence suggests that the amyloid precursor protein (APP) and amyloid beta (Abeta) accumulate in mitochondrial membranes, cause mitochondrial structural and functional damage, and prevent neurons from functioning normally. Oligomeric Abeta is reported to induce intracellular Ca(2+) levels and to promote the excess accumulation of intracellular Ca(2+) into mitochondria, to induce the mitochondrial permeability transition pore to open, and to damage mitochondrial structure. Based on recent gene expression studies of APP transgenic mice and AD postmortem brains, and APP/Abeta and mitochondrial structural studies, we propose that the overexpression of APP and the increased production of Abeta may cause structural changes of mitochondria, including an increase in the production of defective mitochondria, a decrease in mitochondrial trafficking, and the alteration of mitochondrial dynamics in neurons affected by AD. This article discusses some critical issues of APP/Abeta associated with mitochondria, mitochondrial structural and functional damage, and abnormal intracellular calcium regulation in neurons from AD patients. This article also discusses the link between Abeta and impaired mitochondrial dynamics in AD.
Insights
Amyloid precursor protein (APP) and amyloid beta (Abeta) accumulation damages brain cell mitochondria, disrupting neuron function in Alzheimer's disease (AD). This leads to mitochondrial dysfunction and impaired neuronal calcium regulation.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mitochondria are crucial for neuronal energy production.
- Accumulation of amyloid precursor protein (APP) and amyloid beta (Abeta) in brain mitochondria is increasingly implicated in neurodegenerative diseases.
- Mitochondrial dysfunction is a key feature in Alzheimer's disease (AD) pathogenesis.
Purpose of the Study:
- To explore the critical role of APP/Abeta in mitochondrial structural and functional damage within AD neurons.
- To investigate the link between Abeta accumulation, altered intracellular calcium regulation, and impaired mitochondrial dynamics in AD.
- To propose how APP overexpression and Abeta production contribute to mitochondrial abnormalities in AD.
Main Methods:
- Analysis of gene expression in APP transgenic mice and postmortem AD brains.
- Mitochondrial structural and functional studies in relation to APP/Abeta.
- Investigation of intracellular calcium (Ca2+) levels and mitochondrial permeability transition pore opening.
Main Results:
- Oligomeric Abeta induces intracellular Ca2+ overload, leading to mitochondrial permeability transition pore opening and structural damage.
- APP/Abeta accumulation in mitochondrial membranes causes structural and functional deficits in neurons.
- Evidence suggests APP overexpression and increased Abeta production lead to defective mitochondria, reduced trafficking, and altered mitochondrial dynamics in AD.
Conclusions:
- APP/Abeta significantly contributes to mitochondrial damage and dysfunction in AD.
- Impaired mitochondrial dynamics and altered calcium regulation are critical consequences of Abeta accumulation in AD neurons.
- Targeting APP/Abeta interactions with mitochondria may offer therapeutic strategies for AD.
More Related Videos
15:04Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Mitochondria
Mitochondrial Membranes